Aquatic Capital Management LLC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 161 filers reported holding REATA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.

Quarter-by-quarter ownership
Aquatic Capital Management LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$2,837
-5.4%
31,200
+31100.0%
0.18%
+17500.0%
Q2 2022$3,000
-87.0%
100
-85.7%
0.00%
-97.1%
Q1 2022$23,0007000.03%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
CPMG Inc 2,896,901$94,902,00015.92%
Opaleye Management Inc. 407,002$13,333,0004.14%
Ikarian Capital, LLC 649,600$21,281,0002.80%
AWH Capital, L.P. 150,000$2,459,4572.54%
Boxer Capital, LLC 1,239,000$40,590,0002.09%
EcoR1 Capital, LLC 1,975,611$64,721,0002.02%
Camber Capital Management LP 1,500,000$49,140,0001.78%
MPM BioImpact LLC 180,000$5,897,0001.58%
Sofinnova Investments, Inc. 602,545$19,739,0001.50%
KRS Capital Management, LLC 28,141$921,0001.00%
View complete list of REATA PHARMACEUTICALS INC shareholders